3,971 results match your criteria JACC: Cardiovascular Interventions [Journal]


Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines.

JACC Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Department of Cardiology, Bern University Hospital, Bern, Switzerland. Electronic address:

Objectives: This study sought to validate European Society of Cardiology guideline-endorsed high-risk features of stent-related recurrent ischemic events for the prediction of ischemic and bleeding outcomes including a stratification according to the PRECISE-DAPT score estimated bleeding risk.

Background: The 2017 European Society of Cardiology-focused update on dual-antiplatelet therapy endorsed high-risk features of stent-related recurrent ischemic events. Because patients with high ischemic risk also have an increased bleeding risk, appropriate risk stratification for ischemic and bleeding events is crucial. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.005DOI Listing

Operator-Directed Procedural Sedation in the Congenital Cardiac Catheterization Laboratory.

JACC Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Objectives: The purpose of this study was to evaluate the association between the method of procedural sedation and outcomes for congenital cardiac catheterization procedures.

Background: The safety of operator-directed sedation (ODS) in the pediatric/congenital cardiac catheterization laboratory has been questioned. To our knowledge, the relative safety of ODS versus general anesthesia (GA) in these cases has not to date been critically evaluated. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19368798193031
Publisher Site
http://dx.doi.org/10.1016/j.jcin.2019.01.224DOI Listing
April 2019
5 Reads

Undilatable Calcific Coronary Stenosis Causing Stent Underexpansion and Late Stent Thrombosis: A Complex Scenario Successfully Managed With Intravascular Lithotripsy.

JACC Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Interventional Cardiology Unit, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos, Universidad Complutense, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.010DOI Listing

The Gordian Knot-If You Can Not Solve It, Cut It: Treating Guidewire Bending While Obtaining Arterial Access.

JACC Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.040DOI Listing

Fractured Guidewire Entrapped in the Ostium of Right Coronary Artery Mimicking Aortic Flap.

JACC Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Heart Institute and Radiology Department, Kaplan Medical Center, Rehovot, Israel; Hebrew University and Hadassah Medical School, Jerusalem, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.008DOI Listing

Sedation in the Pediatric and Congenital Catheterization Lab: Is It Time We Wake Them Up?

JACC Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Rocky Mountain Pediatric Cardiology, Denver, Colorado.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19368798193046
Publisher Site
http://dx.doi.org/10.1016/j.jcin.2019.02.001DOI Listing
April 2019
2 Reads

Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis.

JACC Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Department of Clinical and Experimental Medicine, "G. Martino" Hospital, University of Messina, Messina, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.212DOI Listing
April 2019
7.345 Impact Factor

Intracranial Embolization and Retrieval of a Sheared Coronary Artery Segment.

JACC Cardiovasc Interv 2019 Apr;12(7):e55-e57

Department of Radiology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.213DOI Listing
April 2019
1 Read
7.345 Impact Factor

Correction.

Authors:

JACC Cardiovasc Interv 2019 Apr;12(7):695-696

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.03.009DOI Listing

Correction.

Authors:

JACC Cardiovasc Interv 2019 Apr;12(7):695

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.03.008DOI Listing

New CENTERA Transcatheter Aortic Valve: Best of the Balloon-Expandable and Self-Expanding Valve Worlds?

Authors:
Alan C Yeung

JACC Cardiovasc Interv 2019 Apr;12(7):681-683

Department of Medicine/Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.024DOI Listing

1-Year Outcomes of the CENTERA-EU Trial Assessing a Novel Self-Expanding Transcatheter Heart Valve.

JACC Cardiovasc Interv 2019 Apr;12(7):673-680

Department of Cardiovascular Surgery, University Heart Center, Hamburg, Germany.

Objectives: The purpose of this study is to report the 1-year results of the CENTERA-EU trial.

Background: The CENTERA transcatheter heart valve (THV) (Edwards Lifesciences, Irvine, California) is a low-profile (14-F eSheath compatible), self-expanding nitinol valve, with a motorized delivery system allowing for repositionability. The 30-day results of the CENTERA-EU trial demonstrated the short-term safety and effectiveness of the valve. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19368798193038
Publisher Site
http://dx.doi.org/10.1016/j.jcin.2019.01.231DOI Listing
April 2019
3 Reads

Axillary/Subclavian Transcatheter Aortic Valve Replacement: The Default Alternative Access?

JACC Cardiovasc Interv 2019 Apr;12(7):670-672

Department of Cardiovascular Surgery, Mount Sinai Health System, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.017DOI Listing
April 2019
1 Read

Outcomes Following Subclavian and Axillary Artery Access for Transcatheter Aortic Valve Replacement: Society of the Thoracic Surgeons/American College of Cardiology TVT Registry Report.

JACC Cardiovasc Interv 2019 Apr;12(7):662-669

Division of Cardiology, University of Washington, Seattle, Washington. Electronic address:

Objectives: The aim of this study was to analyze the frequency and outcomes of patients who underwent transsubclavian or transaxillary (TAx) transcatheter aortic valve replacement (TAVR) using the balloon-expandable SAPIEN 3 prosthesis compared with traditional alternative access, transapical (TA) and transaortic (TAo).

Background: The transsubclavian and TAx approaches for TAVR are rapidly growing alternatives in the setting of hostile iliofemoral arteries, yet few data exist.

Methods: The Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) Registry was queried for all patients undergoing TAx TAVR with the SAPIEN 3 prosthesis from June 2015 to February 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.219DOI Listing
April 2019
3 Reads

Unconfirmed Very Long-Term Clinical Benefit of Xience Over Cypher: Should We Reset Our Vision?

JACC Cardiovasc Interv 2019 Apr;12(7):648-650

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.019DOI Listing

7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial.

JACC Cardiovasc Interv 2019 Apr;12(7):637-647

Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address:

Objectives: The aim of this study was to compare 7-year outcomes between the first-generation sirolimus-eluting stent (SES) and the new-generation everolimus-eluting stent (EES) in a randomized clinical trial.

Background: There is a scarcity of very long-term (beyond 5 years) data from clinical trials investigating whether new-generation drug-eluting stents have clear clinical advantages over first-generation drug-eluting stents.

Methods: RESET (Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial) is the largest randomized trial comparing EES with SES (NCT01035450). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.234DOI Listing

How to SORT OUT an Additional Value From Noninferiority Stent Comparisons?

JACC Cardiovasc Interv 2019 Apr;12(7):634-636

Clinic Cardiovascular Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.228DOI Listing

Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial).

JACC Cardiovasc Interv 2019 Apr;12(7):624-633

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Objectives: The aim of this study was to compare the thin-strut biodegradable-polymer everolimus-eluting platinum-chromium stent (EES) with the biodegradable-polymer biolimus-eluting stainless-steel stent (BES).

Background: Currently available drug-eluting coronary stents have been refined to reduce the risk for coronary events following implantation.

Methods: This randomized, multicenter, all-comers, noninferiority trial was undertaken at 3 sites in western Denmark. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.036DOI Listing

Transcatheter Tumor Biopsy Combined With Balloon Pulmonary Angioplasty in Diagnosing Intravascular Pulmonary Small Cell Carcinoma.

JACC Cardiovasc Interv 2019 Mar 22. Epub 2019 Mar 22.

Division of Cardiology, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.013DOI Listing

The Bounce Back: Should Hospital Readmission Following Percutaneous Coronary Intervention Be the Next Focus of Our Quality Efforts?

Authors:
Michael Ragosta

JACC Cardiovasc Interv 2019 Mar 22. Epub 2019 Mar 22.

University of Virginia Health System, Charlottesville, Virginia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.041DOI Listing
March 2019
1 Read

Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.

JACC Cardiovasc Interv 2019 Mar 22. Epub 2019 Mar 22.

Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom. Electronic address:

Objectives: The aim of this study was to describe the rates and causes of unplanned readmissions at different time periods following percutaneous coronary intervention (PCI).

Background: The rates and causes of readmission at different time periods after PCI remain incompletely elucidated.

Methods: Patients undergoing PCI between 2010 and 2014 in the U. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.007DOI Listing
March 2019
3 Reads
7.345 Impact Factor

Intravascular Ultrasound Findings of the Left Main Coronary Artery Compressed by Primary Lung Carcinoma.

JACC Cardiovasc Interv 2019 Mar 22. Epub 2019 Mar 22.

Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.232DOI Listing

Successful Repair of a Deep Femoral Artery Injury Caused by Femoral Trochanteric Fracture Surgery Using a Polytetrafluoroethylene-Covered Stent.

JACC Cardiovasc Interv 2019 Mar 22. Epub 2019 Mar 22.

Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.016DOI Listing

TAVR: Just How Minimalistic Should It Get?

JACC Cardiovasc Interv 2019 Mar 22. Epub 2019 Mar 22.

Heart Institute (InCor), University of São Paulo, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.048DOI Listing

Pre-Dilatation Versus No Pre-Dilatation for Implantation of a Self-Expanding Valve in All Comers Undergoing TAVR: The DIRECT Trial.

JACC Cardiovasc Interv 2019 Mar 22. Epub 2019 Mar 22.

First Department of Cardiology, Athens School of Medicine, Hippokration Hospital, Athens, Greece.

Objectives: The aim of this study was to compare the implantation of a self-expanding valve with or without balloon aortic valvuloplasty (BAV) in an open-label, noninferiority, randomized trial.

Background: There are no randomized studies comparing the implantation of a self-expanding valve with (pre-BAV) or without BAV.

Methods: Consecutive patients with severe aortic stenosis were randomly assigned to undergo transcatheter aortic valve replacement with the use of self-expanding prostheses with (pre-BAV) or without (no-BAV) pre-dilatation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.005DOI Listing
March 2019
5 Reads

The Implications of Acute Clinical Care Responsibilities on the Contemporary Practice of Interventional Cardiology.

JACC Cardiovasc Interv 2019 Mar;12(6):595-599

Houston Methodist Hospital, Houston, Texas.

The responsibilities of the interventional cardiologist (IC) have evolved in contemporary practice to include substantial acute care clinical duties outside of the cardiac catheterization laboratory. In particular, the IC has assumed a central role in the global management of myocardial infarction and other acute coronary syndromes in the intensive care unit and beyond. These duties have expanded to include many nonprocedural tasks. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.030DOI Listing

Mitral Regurgitation, Atrial Fibrillation, and Transcatheter Mitral Valve Repair.

Authors:
Dritan Poçi

JACC Cardiovasc Interv 2019 Mar;12(6):579-581

Department of Cardiology, Lung Diseases and Clinical Physiology, School of Medical Sciences, Örebro University, Örebro, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.216DOI Listing
March 2019
1 Read

The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

JACC Cardiovasc Interv 2019 Mar;12(6):569-578

Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina. Electronic address:

Objectives: The aim of this study was to compare 1-year outcomes following transcatheter mitral valve (MV) repair in patients with and without atrial fibrillation (AF).

Background: The development of AF in degenerative mitral regurgitation (MR) is considered a sign of MR progression and is associated with adverse clinical events. However, the impact of AF in patients undergoing transcatheter MV repair remains uncertain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.012DOI Listing
March 2019
2 Reads

Sirolimus-Coated Balloons: A Ferrari for Our Coronary Patients or Another Elegant Town Car?

Authors:
Bernardo Cortese

JACC Cardiovasc Interv 2019 Mar;12(6):567-568

Cardiac Department, San Carlo Clinic, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.034DOI Listing

Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.

JACC Cardiovasc Interv 2019 Mar;12(6):558-566

Cardiology Department, University Hospital of Saarland, Homburg/Saar, Germany. Electronic address:

Objectives: The aim of this randomized controlled trial was to investigate a novel sirolimus-coated balloon (SCB) compared with the best investigated paclitaxel-coated balloon (PCB).

Background: Treatment of coronary in-stent restenosis (ISR) remains challenging. PCBs are an established treatment option outside the United States with a Class I, Level of Evidence: A recommendation in the European guidelines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.040DOI Listing
March 2019
2 Reads
7.345 Impact Factor

What Do You Need for Chronic Total Occlusion Recanalization: Swiftness or Skillfulness?

JACC Cardiovasc Interv 2019 Mar;12(6):556-557

Division of Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.214DOI Listing
March 2019
7.345 Impact Factor

Efficacy and Feasibility of the 3-Dimensional Wiring Technique for Chronic Total Occlusion Percutaneous Coronary Intervention: First Report of Outcomes of the 3-Dimensional Wiring Technique.

JACC Cardiovasc Interv 2019 Mar;12(6):545-555

Sakurabashi-Watanabe Hospital, Osaka, Japan.

Objectives: This study sought to compare the procedural outcomes of percutaneous coronary intervention for chronic total occlusion between the periods before and after introduction of 3-dimensional (3D) wiring.

Background: Previously, we reported a 3D wiring method by which the operator can construct real-time mental 3D images from 2 perpendicular angles of X-ray system monitor during percutaneous coronary intervention for chronic total occlusion.

Methods: A total of 137 chronic total occlusion lesions that could not be passed by tapered soft wires in our hospital between 2012 and 2017 were retrospectively enrolled in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.014DOI Listing
March 2019
1 Read

Superficial Calcific Sheets: A Novel Substrate for Acute Coronary Syndromes?

JACC Cardiovasc Interv 2019 Mar;12(6):541-544

Department of Cardiology, Hospital Universitario de La Princesa, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.222DOI Listing

Calcified Plaques in Patients With Acute Coronary Syndromes.

JACC Cardiovasc Interv 2019 Mar;12(6):531-540

Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Cardiology, Kyung Hee University Hospital, Seoul, Republic of Korea. Electronic address:

Objectives: This study conducted detailed analysis of calcified culprit plaques in patients with acute coronary syndromes (ACS).

Background: Calcified plaques as an underlying pathology in patients with ACS have not been systematically studied.

Methods: From 1,241 patients presenting with ACS who had undergone pre-intervention optical coherence tomography imaging, 157 (12. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.013DOI Listing
March 2019
7 Reads

When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis?

JACC Cardiovasc Interv 2019 Mar;12(6):505-517

Department of Cardiology at Ochsner Clinic Foundation, New Orleans, Louisiana.

Atherosclerotic renal artery stenosis is the leading cause of secondary hypertension and may lead to resistant (refractory) hypertension, progressive decline in renal function, and cardiac destabilization syndromes (pulmonary edema, recurrent heart failure, or acute coronary syndromes) despite guideline-directed medical therapy. Although randomized controlled trials comparing medical therapy with medical therapy and renal artery stenting have failed to show a benefit for renal artery stenting, according to comparative effectiveness reviews by the Agency for Healthcare Research and Quality, the trials may not have enrolled patients with the most severe atherosclerotic renal artery stenosis, who would be more likely to benefit from renal stenting. Because of limitations of conventional angiography, it is critical that the hemodynamic severity of moderately severe (50% to 70%) atherosclerotic renal artery stenosis lesions be confirmed on hemodynamic measurement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.023DOI Listing
March 2019
2 Reads

Adaptations to Coronary Physiology in a Patient With Severe Aortic Stenosis and Complete Heart Block Undergoing Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv 2019 Apr 13;12(7):687-689. Epub 2019 Mar 13.

Monash Cardiovascular Research Centre and MonashHeart, Monash University and Monash Health, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.215DOI Listing
April 2019
3 Reads
7.345 Impact Factor

Hemodynamic Effects of Transcatheter Aortic Valve Replacement for Moderate Aortic Stenosis With Reduced Left Ventricular Ejection Fraction.

JACC Cardiovasc Interv 2019 Apr 13;12(7):684-686. Epub 2019 Mar 13.

Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcentrum, Rotterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.244DOI Listing
April 2019
1 Read

Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry.

JACC Cardiovasc Interv 2019 Apr 13;12(7):651-658. Epub 2019 Mar 13.

Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts.

Objectives: This study sought to examine depression prevalence among chronic total occlusion (CTO) patients and compared symptom improvement among depressed and nondepressed patients after percutaneous coronary intervention (PCI).

Background: Depression in cardiovascular patients is common, but its prevalence among CTO patients and its association with PCI response is understudied.

Methods: Among 811 patients from the OPEN-CTO (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures) registry, we evaluated change in health status between baseline and 1-year post-PCI, as measured by the Seattle Angina Questionnaire (SAQ) and the Rose Dyspnea Score. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.12.029DOI Listing
April 2019
1 Read

Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures.

JACC Cardiovasc Interv 2019 Apr 13;12(7):607-620. Epub 2019 Mar 13.

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

Objectives: This study sought to determine whether intravascular ultrasound (IVUS) guidance compared with angiographic guidance reduces long-term risk of cardiac death in patients undergoing complex percutaneous coronary intervention (PCI).

Background: Although IVUS is a useful tool for accurate assessment of lesion profiles and optimal stent implantation, there are limited data on long-term clinical outcomes between IVUS-guided and angiography-guided PCI for patients with complex lesions.

Methods: From March 2003 through December 2015, a total of 6,005 patients undergoing PCI for complex lesions with drug-eluting stents were enrolled from a prospective institutional registry. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.227DOI Listing

A Heartbreaking Sadness: Does Percutaneous Coronary Intervention Breathe New Life Into the Health Status of Patients With Chronic Total Occlusion?

JACC Cardiovasc Interv 2019 Apr 13;12(7):659-661. Epub 2019 Mar 13.

Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.02.002DOI Listing

Distal Bioresorbable Vascular Scaffold Strut Embolization Detected at Late Follow-Up: A New BVS-Related Late Complication.

JACC Cardiovasc Interv 2019 Apr 13;12(7):e63-e65. Epub 2019 Mar 13.

Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.226DOI Listing
April 2019
1 Read

Intravascular Ultrasound for Complex Percutaneous Coronary Intervention: A Far Too Complex Way to Recognition.

JACC Cardiovasc Interv 2019 Apr 13;12(7):621-623. Epub 2019 Mar 13.

Hospital Universitario Marques de Valdecilla, Servicio de Cardiología, Unidad de Cardiología Intervencionista, IDIVAL, Santander, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.01.236DOI Listing
April 2019
2 Reads

Transcatheter Aortic Valve Replacement in Low-Risk Patients: One-Year Results from the LRT Trial.

JACC Cardiovasc Interv 2019 Mar 8. Epub 2019 Mar 8.

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Objectives: To evaluate clinical outcomes and transcatheter heart valve hemodynamics at 1 year after transcatheter aortic valve replacement (TAVR) in low-risk patients.

Background: Early results from the Low Risk TAVR (LRT) trial demonstrated that TAVR is safe in patients with symptomatic severe aortic stenosis (AS) who are low risk for surgical valve replacement.

Methods: The LRT trial was an investigator-initiated, prospective, multicenter study and was the first Food and Drug Administration-approved Investigational Device Exemption trial to evaluate feasibility of TAVR in low-risk patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2019.03.002DOI Listing
March 2019
1 Read